Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early phase 2 study of S-444823 ointment in atopic dermatitis
jRCT2080220964Phase 2
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of S-444823 in atopic dermatitis (AD), sponsored by Shionogi & Co., Ltd.
02
Drugs
S-444823
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080220964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220964.